Forteo ® (teriparatide [rDNA origin] injection)

20-mcg daily dose in a 2.4-mL prefilled delivery device

The below information is provided in response to your request and may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above.

Subcutaneous Injections with FORTEO® (teriparatide [rDNA origin] injection)

Forteo should be administered as a subcutaneous injection into the thigh or abdominal wall

Subcutaneous injection

In clinical trials, Forteo® (teriparatide [rDNA origin] injection) was injected subcutaneously into the patient’s thigh or abdominal wall (Forteo Package Insert, 2012).

  • The upper arm is an acceptable area for subcutaneous injection; however, there are no data available on the injection of teriparatide at this site.

Intravenous or intramuscular injection

There is no data available on the safety or efficacy of intravenous or intramuscular injection of teriparatide.

Instructions for teriparatide injection

Please review the user manual for instructions on how to properly inject teriparatide.

Enclosed Prescribing Information

FORTEO® (teriparatide [rDNA origin] injection), Lilly

The published references below are available upon request by contacting 1-800-LillyRx.

References

FORTEO® [Package Insert]. Indianapolis, IN: Eli Lilly and Company; 2012.

Forteo [User Manual]. Indianapolis, IN: Eli Lilly and Company; 2017.

Date of Last Review: February 09, 2017

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 8pm ET

Or you can

Ask us a question Chat with us

Submit a question

Visit Us @LillyMedical